Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 20, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 20, 2020Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:June 28, 2011Unknown status
Condition(s):Sarcoidosis; Pulmonary HypertensionLast Updated:December 8, 2015Unknown status
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 18, 2023Terminated
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 27, 2024Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:February 17, 2016Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:February 20, 2024Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 19, 2024Recruiting
Condition(s):Hypertension, PulmonaryLast Updated:November 5, 2021Completed
Condition(s):Chronic Thromboembolic Pulmonary Hypertension; Idiopathic Pulmonary Arterial HypertensionLast Updated:June 24, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.